Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rodriguez-Aguirre ME"'
Autor:
Baltgalvis KA; Vividion Therapeutics, San Diego, CA, USA., Lamb KN; Vividion Therapeutics, San Diego, CA, USA., Symons KT; Vividion Therapeutics, San Diego, CA, USA., Wu CC; Vividion Therapeutics, San Diego, CA, USA., Hoffman MA; Vividion Therapeutics, San Diego, CA, USA., Snead AN; Vividion Therapeutics, San Diego, CA, USA., Song X; Vividion Therapeutics, San Diego, CA, USA., Glaza T; Vividion Therapeutics, San Diego, CA, USA., Kikuchi S; Vividion Therapeutics, San Diego, CA, USA., Green JC; Vividion Therapeutics, San Diego, CA, USA., Rogness DC; Vividion Therapeutics, San Diego, CA, USA., Lam B; Vividion Therapeutics, San Diego, CA, USA., Rodriguez-Aguirre ME; Vividion Therapeutics, San Diego, CA, USA., Woody DR; Vividion Therapeutics, San Diego, CA, USA., Eissler CL; Vividion Therapeutics, San Diego, CA, USA., Rodiles S; Vividion Therapeutics, San Diego, CA, USA., Negron SM; Vividion Therapeutics, San Diego, CA, USA., Bernard SM; Vividion Therapeutics, San Diego, CA, USA., Tran E; Vividion Therapeutics, San Diego, CA, USA., Pollock J; Vividion Therapeutics, San Diego, CA, USA., Tabatabaei A; Vividion Therapeutics, San Diego, CA, USA., Contreras V; Vividion Therapeutics, San Diego, CA, USA., Williams HN; Vividion Therapeutics, San Diego, CA, USA., Pastuszka MK; Vividion Therapeutics, San Diego, CA, USA., Sigler JJ; Vividion Therapeutics, San Diego, CA, USA., Pettazzoni P; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Rudolph MG; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Classen M; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Brugger D; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Claiborne C; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Plancher JM; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Cuartas I; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain., Seoane J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain., Burgess LE; Vividion Therapeutics, San Diego, CA, USA., Abraham RT; Vividion Therapeutics, San Diego, CA, USA.; Odyssey Therapeutics, San Diego, CA, USA., Weinstein DS; Vividion Therapeutics, San Diego, CA, USA., Simon GM; Vividion Therapeutics, San Diego, CA, USA., Patricelli MP; Vividion Therapeutics, San Diego, CA, USA. mattp@vividion.com., Kinsella TM; Vividion Therapeutics, San Diego, CA, USA. tkinsella71c@gmail.com.
Publikováno v:
Nature [Nature] 2024 Jul; Vol. 631 (8021), pp. E12.
Autor:
Baltgalvis KA; Vividion Therapeutics, San Diego, CA, USA., Lamb KN; Vividion Therapeutics, San Diego, CA, USA., Symons KT; Vividion Therapeutics, San Diego, CA, USA., Wu CC; Vividion Therapeutics, San Diego, CA, USA., Hoffman MA; Vividion Therapeutics, San Diego, CA, USA., Snead AN; Vividion Therapeutics, San Diego, CA, USA., Song X; Vividion Therapeutics, San Diego, CA, USA., Glaza T; Vividion Therapeutics, San Diego, CA, USA., Kikuchi S; Vividion Therapeutics, San Diego, CA, USA., Green JC; Vividion Therapeutics, San Diego, CA, USA., Rogness DC; Vividion Therapeutics, San Diego, CA, USA., Lam B; Vividion Therapeutics, San Diego, CA, USA., Rodriguez-Aguirre ME; Vividion Therapeutics, San Diego, CA, USA., Woody DR; Vividion Therapeutics, San Diego, CA, USA., Eissler CL; Vividion Therapeutics, San Diego, CA, USA., Rodiles S; Vividion Therapeutics, San Diego, CA, USA., Negron SM; Vividion Therapeutics, San Diego, CA, USA., Bernard SM; Vividion Therapeutics, San Diego, CA, USA., Tran E; Vividion Therapeutics, San Diego, CA, USA., Pollock J; Vividion Therapeutics, San Diego, CA, USA., Tabatabaei A; Vividion Therapeutics, San Diego, CA, USA., Contreras V; Vividion Therapeutics, San Diego, CA, USA., Williams HN; Vividion Therapeutics, San Diego, CA, USA., Pastuszka MK; Vividion Therapeutics, San Diego, CA, USA., Sigler JJ; Vividion Therapeutics, San Diego, CA, USA., Pettazzoni P; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Rudolph MG; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Classen M; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Brugger D; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Claiborne C; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Plancher JM; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Cuartas I; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain., Seoane J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain., Burgess LE; Vividion Therapeutics, San Diego, CA, USA., Abraham RT; Vividion Therapeutics, San Diego, CA, USA.; Odyssey Therapeutics, San Diego, CA, USA., Weinstein DS; Vividion Therapeutics, San Diego, CA, USA., Simon GM; Vividion Therapeutics, San Diego, CA, USA., Patricelli MP; Vividion Therapeutics, San Diego, CA, USA. mattp@vividion.com., Kinsella TM; Vividion Therapeutics, San Diego, CA, USA. tkinsella71c@gmail.com.
Publikováno v:
Nature [Nature] 2024 May; Vol. 629 (8011), pp. 435-442. Date of Electronic Publication: 2024 Apr 24.
Autor:
Mitchell LA; Tocagen Inc., San Diego, 92121, CA, USA., Yagiz K; Tocagen Inc., San Diego, 92121, CA, USA., Hofacre A; Tocagen Inc., San Diego, 92121, CA, USA., Viaud S; Tocagen Inc., San Diego, 92121, CA, USA., Munday AW; Tocagen Inc., San Diego, 92121, CA, USA., Espinoza FL; Tocagen Inc., San Diego, 92121, CA, USA., Mendoza D; Tocagen Inc., San Diego, 92121, CA, USA., Rodriguez-Aguirre ME; Tocagen Inc., San Diego, 92121, CA, USA., Bergqvist S; Biofizik, Inc., San Diego, 92121, CA, USA., Haghighi A; Tocagen Inc., San Diego, 92121, CA, USA., Miner MV; Tocagen Inc., San Diego, 92121, CA, USA., Accomando WP; Tocagen Inc., San Diego, 92121, CA, USA., Burrascano C; Tocagen Inc., San Diego, 92121, CA, USA., Gammon D; Tocagen Inc., San Diego, 92121, CA, USA., Gruber HE; Tocagen Inc., San Diego, 92121, CA, USA., Jolly DJ; Tocagen Inc., San Diego, 92121, CA, USA., Lin AH; Tocagen Inc., San Diego, 92121, CA, USA.
Publikováno v:
Oncotarget [Oncotarget] 2019 Mar 19; Vol. 10 (23), pp. 2252-2269. Date of Electronic Publication: 2019 Mar 19 (Print Publication: 2019).
Autor:
Yagiz K; Tocagen Inc., 3030 Bunker Hill St., Suite 230, San Diego, CA 92109, USA., Rodriguez-Aguirre ME; Tocagen Inc., 3030 Bunker Hill St., Suite 230, San Diego, CA 92109, USA., Lopez Espinoza F; Tocagen Inc., 3030 Bunker Hill St., Suite 230, San Diego, CA 92109, USA., Montellano TT; Tocagen Inc., 3030 Bunker Hill St., Suite 230, San Diego, CA 92109, USA., Mendoza D; Tocagen Inc., 3030 Bunker Hill St., Suite 230, San Diego, CA 92109, USA., Mitchell LA; Tocagen Inc., 3030 Bunker Hill St., Suite 230, San Diego, CA 92109, USA., Ibanez CE; Tocagen Inc., 3030 Bunker Hill St., Suite 230, San Diego, CA 92109, USA., Kasahara N; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA., Gruber HE; Tocagen Inc., 3030 Bunker Hill St., Suite 230, San Diego, CA 92109, USA., Jolly DJ; Tocagen Inc., 3030 Bunker Hill St., Suite 230, San Diego, CA 92109, USA., Robbins JM; Tocagen Inc., 3030 Bunker Hill St., Suite 230, San Diego, CA 92109, USA.; DNAtrix, Inc., 2450 Holcombe Boulevard, Suite X+ 200, Houston, TX 77021, USA.
Publikováno v:
Molecular therapy oncolytics [Mol Ther Oncolytics] 2017 Dec 05; Vol. 8, pp. 14-26. Date of Electronic Publication: 2017 Dec 05 (Print Publication: 2018).